Aicardi-Goutiè res syndrome (AGS) is the name given to a severe inflammatory neurological disease first described in 1984. While there is a robust association between enhanced type I interferon signaling and affected status, AGS is genetically heterogeneous and can occur due to mutations in proteins involved in RNA sensing (MDA5) or DNA and RNA processing (TREX1, the RNase H2 complex, SAMHD1, and ADAR1). As AGS's clinical phenotype is reminiscent of in utero acquired congenital infection, and given the central role of viral nucleic acid in interferon induction, it has been hypothesized that the aberrant recognition of self-derived nucleic acids as nonself may underlie disease pathogenesis. However, the precise nature of self DNA and RNA that might trigger an inappropriate interferon response in AGS has remained unclear (Stetson et al., 2008; Crow and Manel, 2015) .
In this issue of Cell, Sun Hur and colleagues utilize knowledge of the effects of AGS-causing gain-of-function (GOF) mutations in MDA5 to explore the biology of this cytosolic double-stranded RNA (dsRNA) sensor. First, they show that mutation-associated enhanced interferon signaling is dependent on the ability to bind an endogenous ligand, not due to constitutive activation of the receptor (Ahmad et al., 2018) . As MDA5 binding can protect agonist dsRNA from RNase digestion, they could then sequence MDA5 ligands and demonstrate that Alu-Alu inverted repeats (IR-Alus), largely derived from the 3 0 UTR of retrotransposition-incompetent RNA polymerase II (pol II) transcripts, are the primary endogenous ligand of mutant MDA5. Alu is a 300-nucleotide-long retroelement that constitutes 10% of the human genome. In a series of elegant experiments, Ahmad et al. show that up to 25% of cytosolic Alu RNA is in the form of Alu-Alu hybrids. However, the reason for Alu being the primary ligand for MDA5 is not just because it is abundant, but also because of its high level of sequence conservation, making IR-Alu more likely to assemble in a hairpin structure based on complementarity.
Importantly, Alu:Alu hybrids are posttranscriptionally modified by ADAR1, which converts adenosine to inosine (A-to-I)-the most common type of RNA editing in humans-thereby weakening dsRNA integrity. Ahmad et al. show that A-to-I edits render IR-Alus immunologically inert with respect to wild-type (WT) MDA5 due to mismatches and bulges within the duplex (Figure 1 ). In contrast, mutant MDA5 is indifferent to these modifications. Importantly, AGS has been shown to result from either MDA5 GOF or hypomorphic mutations in ADAR1. Using ADAR1-KO (knockout) cells, Hur and colleagues demonstrate that WT MDA5 can mediate an interferon response to endogenous IR-Alus, which are immunogenic in the absence of editing. Thus, normally, WT MDA5 does not recognize Alu:Alu hybrids because it is sensitive to ADAR1-mediated A-to-I modifications. In contrast, MDA5 GOF mutants tolerate such dsRNA structural irregularities, forming productive filaments on Alu:Alu hybrids and triggering aberrant antiviral signaling. Meanwhile, a deficiency of ADAR1 means that the structural integrity of (unedited) IR-Alus is maintained, thereby breaching the immune tolerance of WT MDA5.
In a second paper in this same issue, Charlie Rice and colleagues describe the generation of ADAR1 and ADAR1p150 KO 293T human cells in order to define the ADAR1-specific editome, and the impact of ADAR1 on gene expression, in the presence or absence of type I interferon stimulation (Chung et al., 2018) . Consistent with the work of Ahmad et al., they find that most editing events occur in pol-II-dependent Alu elements. Overall editing levels increased with interferon beta treatment and were dependent on the interferon-inducible p150 isoform of ADAR1, with most edited sites detected in genes that are not specifically induced by interferon. A lack of ADAR1 protein, and genome-wide A-to-I editing, did not affect overall gene expression Left: Alu-Alu inverted repeats (IR-Alus) are derived from the 3 0 UTR of retrotransposition-incompetent pol II transcripts and are recognized by ADAR1 prior to nuclear export. Editing of IR-Alu by wild-type (WT) ADAR1 leads to destabilization of the double-stranded RNA (dsRNA), thereby preventing induction of an innate immune response by weakening binding to the WT allele of the cytosolic receptor MDA5. Of note, although 512-nt single-strand RNA (ssRNA) can induce MDA5 signaling in vitro, the RNA-rich cellular environment serves as a pool of competitor RNAs that dilute MDA5 molecules, preventing the formation of an aberrant signaling complex on non-agonist RNAs in the cell. ADAR1 mutant proteins are unable to edit dsRNA, resulting in an increased pool of non-edited IR-Alu that triggers WT MDA5-mediated interferon (IFN) production. Alternatively, binding to gain-offunction (GOF) mutant MDA5 proteins is not affected by ADAR1-mediated editing due to a relative insensitivity to the introduced structural irregularities. Thus, either ADAR1 deficiency or MDA5 GOF is sufficient to induce the formation of MDA5 filaments through homotypic interactions of caspase activation and recruitment domains (2CARD). This then triggers the monomer-to-filament transition of MAVS CARD, which is necessary for downstream IFN signal activation through IRF3. Right: IFNs induce interferon-stimulated gene (ISG) production, including the N-terminally extended ADAR1p150 isoform, MDA5, and PKR. ADAR1p150 contains a nuclear export signal for localization to the cytosol. Here, it processes (more) Alu hairpins contained in 3 0 UTRs of mature mRNAs, thus limiting the propagation of an otherwise positive feedback cycle that involves MDA5 and the activation of PKR. Indeed, Rice and colleagues propose a second role of ADAR1 in modulating the response to IFN in neuronal progenitor cells (NPCs) by preventing activation of PKR and thereby translational shutdown and apoptotic cell death. The mechanism of this inhibition is yet to be clarified, with possibilities including that ADAR1p150 modulates dsRNA detection by PKR and that dsRNA elements containing inosines bind PKR and inhibit activation.
at the mRNA level. However, following interferon exposure, global protein levels were significantly lower in ADAR1 KO and ADAR1p150 KO cells, with ADAR1-deficient cells undergoing translational shutdown and reduced proliferation. This effect was likely mediated by the PKR-dependent activation of eIF2a. Furthermore, this cellular phenotype was dependent on newly transcribed RNA, suggesting that ADAR1 prevents the activation of PKR by interferon-regulated endogenous transcripts, the nature of which remain undefined.
Chung et al. go on to show that ADAR1-deficient neuronal progenitor cells (NPCs), in contrast to ADAR1-deficient 293T cells and ADAR1 KO human embryonic stem cells, demonstrate a spontaneous upregulation of type I interferon signaling, enhanced PKR phosphorylation, and increased apoptosis, effects that were specifically mediated by MDA5. These data are exciting in indicating the potential of induced pluripotent stem cell technology to generate biologically valid experimental systems of AGS and chime with a recent report studying the role of retroelements in TREX1 deficiency (Thomas et al., 2017) . So far, no rodent model recapitulates the neurological damage that is so prominent in patients with AGS. Alus are primate specific, suggesting that differences in the retroelement repertoire of distinct species might explain this observation. Clarification of this issue-and questions of cell-type specificity and selective tissue involvement-represent important areas of future research.
Taken together, these two papers indicate that ADAR1 acts as both a negative regulator of interferon production and as a regulator of the response to interferon. In view of their ''receptor-ligand'' relationship, MDA5 GOF and reduced ADAR1 activity might be expected to result in the same phenotype. Indeed, this is in part the case. However-possibly linked to the role of ADAR1 in preventing translational shutdown following interferon exposure-acute destruction of the basal ganglia is apparently specific to ADAR1-related dysfunction, where historical data indicate that acute basal ganglia necrosis can be triggered by an infectious exposure .
How MDA5 GOF mutations confer sensitivity to ADAR1-mediated dsRNA structural modifications remains unclear, although it seems reasonable to suggest that these variants in some way reshape imperfect dsRNA to support filament assembly. It is tempting to speculate that more common polymorphisms in MDA5, and possibly other viral nucleic acid receptors, might reflect an evolutionary trade-off between the ability to fight infection and the risk of autoinflammation inherent in the adoption of nucleic acid sensing as an antiviral strategy (Gorman et al., 2017) . More generally, these new insights highlight the blurring of the conceptual distinction between self and non-self when considering endogenous retroelements (Mu et al., 2016) and provide the strongest evidence so far that bulk retroelement transcripts can directly drive Mendelian disease.
